The spinal cord injury problem is expected to be overcome in the next three to five years

"Translational medicine" will continue to have new clinical breakthroughs in the field of emerging cell therapeutics. This morning at the Tongji Hospital Affiliated Tongji Hospital, Professor Tong Yi, Chairman of the Academic Committee of the Forum stated that in the next 3-5 years, stem cell therapy is expected to overcome a worldwide problem - spinal cord injury. .

It is understood that a total investment of 100 million yuan was established at the Tongji University Stem Cell Research Center Tongji Hospital Clinical Conversion Center at the end of last year to establish a domestic first-class stem cell infrastructure and transformation research institute for development goals. It has been introduced and established at the University of California, Los Angeles. A nearly 20-member stem cell research team with associate professor (lifetime) and professor Sun Yi of Tongji University as the core team is dedicated to the effective “convergence” of stem cell basic research and clinical application.

Sun Yi said in an interview with this newspaper that in recent years, stem cells have become the most promising research field in the life sciences. The breakthrough achievements of the stem cell transplantation technology in the treatment of major diseases such as neurodegenerative diseases, autoimmune diseases, and leukemia are even more exciting. She also said that stem cell research in the future work of Tongji Hospital's clinical translation center is mainly to treat spinal cord injury with cell transplantation and establish a clinical standardization system for stem cell treatment of spinal cord injury. In the near future, it will also extend to the research field of stem cells for other diseases such as Parkinson's disease.

The “2011 Tongji Stem Cell Transduction Medicine International Forum” sponsored by Tongji Hospital, Tongji University and Tongji University’s Stem Cell Research Center invited experts from stem cell research fields from China, the US and Japan to use stem cells internationally. He gave lectures on the latest developments in the treatment of diseases and innovative technologies in clinical treatment. It is reported that at the end of this month, the California Institute of Regenerative Medicine and the Stem Cell Clinical Conversion Research Center of Tongji Hospital will sign a contract to jointly establish a "Sino-American Stem Cell Transformation Research Center in China and the United States."